Clinical Trial Search

Primary: Percentage of Subjects With Non-surgical Resolution of Focal VMT/sVMA at Day 28, as Determined by Central Reading Center (CRC) Spectral Domain Optical Coherence…

Primary: Change From Baseline in the Major Symptom Complex (MSC) Score Over Period I — -3.46; -6.58; -5.65 units on a scale — p=<0.001

Primary: Change in Relative Abundance of Lactobacillus Species — .0084; -.0014; -.00004; .0104 relative abundance

Primary: Number of Participants With Vaginal Birth After Cesarean (VBAC) — 12; 22 Participants

Primary: Waking Time - Re-establishment of the Gag Reflex. — 16.45; 9.57 minutes — p=0.002

Primary: Procedure Time — 9.5; 9.9 minutes

Primary: Number of Participants With Postoperative Pulmonary Complications — 8; 8 Participants — p=1.00

Primary: Assess the Mean Area Under the Curve (AUC) for Blood Glucose Concentration in Subjects Treated With Either Insulin Detemir Mixed With Rapid Acting Insulin (RAI) or…

Primary: Better Targeted Blood Glucose Levels — 184.1; 179.4; 153.6; 181.5 mg/dl — p=0.003

Primary: Patient Reported Preference for Movantik or PEG 3350 for Opioid-induced Constipation (OIC) Treatment — 124; 118; 4 Participants

Primary: Gastric Emptying — 0.27; 0.384; 0.04; 0.051 percent meal retention — p=0.003

Primary: Change From Baseline Menses for Participant Perceived Blood Loss — 3; 1.9 score on a scale

Primary: Number of Participants Evaluating ENG as Acceptable: Acceptability (Measurement: Questionnaire) — 9; 8 Participants

Primary: Change in Tear Break up Time (TBUT) — -0.86; -0.59; -2.00; 0.27 seconds — p=0.005

Primary: Percentage of Critically Ill Patients With Acute Brain Injury Achieving Pre-specified Feasibility Criteria — 0; 87.5; 0 percentage of patients